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We have tested the hypothesis that the flavivirus nonstructural protein NS3 is a viral proteinase that
generates the termini of several nonstructural proteins by using an efficient in vitro expression system and
monospecific antisera directed against the nonstructural proteins NS2B and NS3. A series of cDNA constructs
was transcribed by using T7 RNA polymerase, and the RNA was translated in reticulocyte lysates. The
resulting protein patterns indicated that proteolytic processing occurred in vitro to generate NS2B and NS3.
The amino termini of NS2B and NS3 produced in vitro were found to be the same as the termini of NS2B and
NS3 isolated from infected cells. Deletion analysis of cDNA constructs localized the protease domain within NS3
to the first 184 amino acids but did not eliminate the possibility that sequences within NS2B were also required
for proper cleavage. Kinetic analysis of processing events in vitro and experiments to examine the sensitivity
of processing to dilution suggested that an intramolecular cleavage between NS2A and NS2B preceded an
intramolecular cleavage between NS2B and NS3. The data from these expression experiments confirm that NS3
is the viral proteinase responsible for cleavage events generating the amino termini of NS2B and NS3 and
presumably for cleavages generating the termini of NS4A and NS5 as well.
The dengue viruses belong to the Flaviviridae, a family of
approximately 70 viruses, most of which are arthropod
borne, which can be grouped into eight antigenic complexes
(6, 7). There are four serotypes of dengue virus, and all are
involved in worldwide epidemics of increasing proportion
(18, 24, 45). Our laboratory has been working with the PR159
Si (candidate vaccine) strain of dengue virus type 2 (1, 2, 17,
27, 46). The PR159 genome is a positive-stranded RNA
molecule 10,712 nucleotides in length that is capped at the 5'
terminus with a type 1 cap and has at the 3' terminus a
uridine residue (11, 27, 53). Translation begins at nucleotide
97 and continues for 10,173 bases to produce a 3,391-amino-
acid polyprotein that is both co- and posttranslationally
processed into at least 10 different polypeptides (47).
Sequence analysis of flavivirus proteins and in vitro
expression experiments have implicated host cell signalases
in the amino-terminal processing of prM, E, and NS1 and
possibly NS2A and NS4B (4, 9, 12, 19, 23, 35, 37, 44, 54).
These host cell signalases cleave on the carboxy-terminal
side of hydrophobic leader sequences and function in the
lumen of the endoplasmic reticulum (51). On the other hand,
the cleavages that generate the amino termini ofNS2B, NS3,
NS4A, and NS5, which follow two basic amino acids and
occur in the cytosol, are believed to be due to a viral
proteinase (39, 41).
The short half-lives of polyprotein precursors in vivo
combined with the poor fidelity of in vitro expression sys-
tems have made the study of flaviviral polyprotein process-
ing difficult. Early experiments that translated genomic RNA
in vitro did not produce detectable amounts of nonstructural
proteins, and correct processing of structural proteins oc-
curred only in the presence of exogenously supplied mi-
crosomal membranes (50, 52). In vivo pulse-chase experi-
ments that utilized amino acid analogs or starved cells prior
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to amino acid labeling enabled the detection of dengue
virus-specific higher-molecular-weight proteins, but the lack
of specific immune reagents and the inability to chase these
putative precursors limited the experimental analysis (10,
38). Recent studies utilizing improved expression systems
have made progress in analyzing signalase-mediated cleav-
age events but have not addressed the cleavages that occur
after dibasic amino acids (19, 35, 37, 44).
Recently, two laboratories have proposed models predict-
ing that the amino terminus of NS3 is a trypsin-like protease
(3, 20), on the basis of limited sequence similarity to cellular
serine proteases and more extensive similarity to the prote-
ase domain of the capsid protein of the alphavirus Sindbis
virus (25, 26). These molecular modeling studies predict that
His-51, Asp-75, and Ser-135 of NS3 form a classic serine
protease catalytic triad and that the entire protease domain
lies within the first 180 amino acids of this protein. The
proteolytic activity of this NS3 enzyme is thought to be
responsible for cleavages generating the amino termini of
NS2B, NS3, NS4A, and NS5 and possibly the carboxy
terminus of the capsid protein. To test this model, we have
developed an efficient in vitro expression system for NS2B
and NS3 and generated specific immune reagents reactive
with these proteins. In this system, the processing events
that generate the amino termini of NS2B and NS3 occur
faithfully in vitro, mediated by the nonstructural protein
NS3. By deletion analysis, the protease domain has been
mapped to within the first 184 amino acids of NS3, and from
the kinetics of cleavage we propose that an intramolecular
cleavage between NS2A and NS2B precedes an intramolec-
ular cleavage between NS2B and NS3.
MATERIALS AND METHODS
Construction of trpE fusions. cDNA clones of the PR159
strain of dengue virus type 2 were used for all plasmid
constructions (27). All plasmids were constructed by using
standard recombinant DNA techniques and were purified on
CsCl density gradients (34). To create a gene fusion between
trpE and dengue virus NS2B, the vector pATH3 (49) was
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digested with BamHI and the 3' recessed end was filled in by
using the Escherichia coli DNA polymerase I Klenow frag-
ment and then digested with ClaI. A fragment from StuI to
HpaII (from cDNA clone 2, referred to here as pDN2)
containing nucleotides 4077 to 4463 of the dengue virus
genome was inserted to yield the construct pTNS2.
To create a gene fusion with NS3, the vector pATH3 was
digested with EcoRI, treated with Klenow fragment, and
digested with Sall. A fragment from Asp718 (Klenow
treated) to Sall (from cDNA clone pDN2) containing nucle-
otides 4497 to 4944 of the dengue virus genome was inserted
to produce pTNS3. Recombinant clones were screened by
analysis of protein expression patterns, restriction endonu-
clease digestion, and DNA sequencing.
Expression of fusion proteins and immunizations. trpE
fusion proteins were prepared from large-scale induced
cultures essentially as described previously (28), with the
following modifications. All trpE plasmids were propagated
in bacterial strain XL1 (Stratagene). After induction, pel-
leted cells were frozen and thawed (two cycles) in 50 mM
Tris (pH 7.5)-0.5 mM EDTA-300 mM NaCl (TEN) buffer.
To promote efficient lysis, cells were treated for 15 min in a
sonicating water bath (Bransonic 12; Branson Sonic Power
Co., Danbury, Conn.) at 4°C. Insoluble inclusion bodies
were purified by two successive pelletings through a 25%
sucrose-1 mM EDTA cushion and were solubilized directly
into sodium dodecyl sulfate (SDS) loading buffer (33) for
electrophoresis in preparative 10% polyacrylamide-SDS gels
(SDS-PAGE). Proteins were visualized by staining with 250
mM KCI at 4°C. Gels were homogenized in sterile phos-
phate-buffered saline (pH 7.5) and mixed with MPL adjuvant
(RIBI Immunochem) prior to injection. New Zealand White
rabbits were injected intramuscularly and subcutaneously on
a 3- to 4-week schedule with 100 to 150 ,ug of fusion protein
per injection session and were bled 10 to 14 days after being
given a booster dose. Serum samples were stored at -20°C
until further use.
Cells and virus stocks. Stocks of the PR159 dengue virus
type 2 Si isolate (1, 2, 46) were prepared on Aedes albopic-
tus C6/36 cells essentially as described previously (13). C6/36
cells were propagated at 30°C in Dulbecco modified Eagle
medium containing 10% fetal calf serum and supplemented
with nonessential amino acids. BHK-21 clone 15 cells,
obtained from Joel Dalrymple, U.S. Army Medical Research
Institute for Infectious Diseases, Bethesda, Md., were used
to plaque purify the virus and to prepare infected cell lysates
for immunoprecipitation. BHK cells were propagated at
37°C in minimum essential medium supplemented with non-
essential amino acids and containing 5% fetal calf serum.
Plaque assays were performed at 34°C on BHK cells by
using a 1% low-melting-temperature agarose (SeaKem; FMC
Corp., Marine Colloids Div., Rockland, Maine) overlay
containing minimum essential medium and 5% fetal calf
serum. Plaques were readily visible after 4 days by direct
visualization or after staining the monolayer with neutral
red.
Labeling of infected cells. Equivalent conditions were used
to prepare labeled viral proteins for immunoprecipitation
assays and amino-terminal sequencing. BHK cells were
infected with dengue virus at a multiplicity of 5 in minimum
essential medium. At 30 h postinfection, cells were labeled in
minimum essential medium containing 2% dialyzed fetal calf
serum, 1/40 the normal concentration of methionine, and 75
,uCi of [35S]methionine (Amersham Corp., Arlington Heights,
Ill.) per ml for 12 h. For preparation of leucine-labeled
proteins, cells were incubated in minimum essential medium
containing 2% dialyzed serum, 1/100 the normal amount of
leucine, and 75 ,uCi of [3H]leucine (New England Nuclear
Corp., Boston, Mass.) per ml for 12 h. Cell lysates were
prepared by solubilizing the monolayers in a denaturing lysis
buffer containing 0.5% SDS, 50 mM Tris (pH 7.5), 150 mM
NaCl, 1 mM EDTA, 20 ,ug of phenylmethylsulfonyl fluoride
(Sigma Chemical Co., St. Louis, Mo.) per ml, 2 jig of
aprotinin (Boehringer Mannheim Biochemicals, Indianapo-
lis, Ind.) per ml, and 2 ,ug of leupeptin (Sigma) per ml.
Translation constructs. Vector pS'L213 was constructed to
facilitate high-level expression of dengue virus sequences in
an in vitro translation system. Briefly, a fragment from
EcoRI to PstI encoding nucleotides 16 to 213 of the dengue
virus type 2 genome (from pDNC3) was cloned into EcoRI-
and PstI-digested pGEM1 (Promega Biotec, Madison, Wis.)
to yield pGem16/213. A double-stranded DNA oligonucleo-
tide that contained a T7 RNA polymerase promoter imme-
diately adjacent to the first 55 nucleotides of the dengue virus
genome (the sequence of the first 15 nucleotides was as-
sumed to be the same as for the dengue virus type 2 Jamaica
strain [15]) was synthesized and was inserted into Sacl-
PvuII-digested pGeml6/213, yielding vector pS'213. pS'213
and pGEM4 were digested with PstI and NheI, and poly-
linker sequences of pGem4 (a fragment from PstI to NheI)
were inserted to yield vector pS'L213. Vector pS'L213
contains several unique restriction sites that allow fusion of
heterologous sequences with the dengue virus capsid gene
reading frame.
Vector pS'L213 was digested with PstI, and the 3' over-
hang was made blunt by treatment with T4 DNA polymerase
and digested with EcoRI. An AseI (Klenow treated)- to
XhoI-digested fragment containing nucleotides 3778 to 5427
of the dengue virus genome, from cDNA clone pDN2, and a
fragment from XhoI to EcoRI containing nucleotides 5428 to
6351 of the dengue virus genome, from cDNA clone pDN5,
were inserted to create pT10. This construct contains the 5'
untranslated region of the dengue virus genome and the
nucleotides encoding the first 37 amino acids of the dengue
virus capsid protein fused in frame to codon 101 of NS2A,
followed by the sequences encoding the remainder of NS2A(amino acids 101 to 218), the complete coding sequences of
NS2B (amino acids 1 to 129), and the first 610 amino acids of
NS3 (the carboxy-terminal 8 amino acids of NS3, amino
acids 611 to 618, are not present).
Proteins produced in vitro with the same termini as those
in vivo have been designated by the prefix NS, whereas
proteins with an altered structure have been designated by
the prefix P and a prime superscript. For example, pTlO-
programmed translations yield the precursor P2A2B3, the
processing intermediate P2B3, and the products P2A, NS2B,
and P3. Precursors, intermediates, and products (described
below) generated by the proteolytically active deletion con-
structs pTll and pT12 are designated P2A2B3', P2A2B3",
P2B3', P2B3", P2A, NS2B, P3', and P3", respectively.
Plasmid pTlO was used to produce deletion clones to map
the boundaries of the protease domain, by using XhoI,
AsuII, Sall, and KpnI (Asp718) restriction sites within NS2B
and NS3. In each case, pTlO was digested with EcoRI and
the second enzyme (XhoI, AsuII, etc.), the 3'-recessed ends
were filled in with Klenow, and the plasmid was recircular-
ized by using T4 DNA ligase to create the deleted constructs
designated pTll, pT12, pT13, and pT14.
Two additional deletion clones were constructed that
together removed almost all the NS2A- and NS2B-coding
sequences represented in pT10. pTll was digested with
KpnI, blunt ended with T4 DNA polymerase, and then
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digested with SnaBI and cyclized to create pT15. pT12 was
digested with PvuII and SnaBI and then cyclized to create
pT16.
In vitro transcription and translation. All plasmids used for
in vitro transcription and translation were purified by CsCl
density gradient centrifugation. After linearization with ap-
propriate restriction enzymes, templates were digested with
proteinase K and phenol extracted. Ethanol-precipitated
templates were suspended in diethylpyrocarbonate-treated
RNase-free water at a concentration of 0.5,ug/ml. Transcrip-
tion reaction mixtures containing 0.5 mM ribonucleoside
triphosphates (Pharmacia, Inc., Piscataway, N.J.), 0.5 mM
cap analog m7G(5')ppp(5')G (New England BioLabs, Inc.,
Beverly, Mass.), 50 ng of template per RI, and 2 U of T7
RNA polymerase (Pharmacia) per RI in lx transcription
buffer (42) were incubated at 37°C for 45 min. The quality of
synthesized RNA was routinely checked by gel electropho-
resis prior to in vitro translation, and the mass of RNA
synthesized was quantitated by inclusion of trace amounts of
[3H]rGTP in the transcription mix. RNA yields were approx-
imately S to 10 p.g of RNA per ,ug of input template.
Micrococcal nuclease-treated rabbit reticulocyte lysates
containing 0.025 eq of microsomal membranes (Promega)
per pul were programmed with in vitro-transcribed RNA at a
concentration of 5 to 10,ug/ml. All translations were carried
out at 30°C for 90 min unless otherwise noted.
Immunoprecipitation. The amount of antiserum necessary
to quantitatively immunoprecipitate radiolabeled viral pro-
teins from cell lysates and in vitro translation mixes was
empirically determined. Labeled cell lysates were diluted
fivefold with radioimmune precipitation (RIPA) buffer (1%
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 0.15 M
NaCl, 50 mM Tris hydrochloride, pH 7.5) prior to immuno-
precipitation, and protein A agarose beads (Boehringer
Mannheim) were used at a fivefold binding excess over
immune sera (31). After a 1-h incubation at room tempera-
ture, the immune complexes were washed twice with RIPA
buffer containing 1 mg bovine serum albumin per ml and
once with RIPA buffer lacking albumin. For immunoprecip-
itation of in vitro translations, reticulocyte lysates were
diluted 25-fold in denaturing lysis buffer and heated to 70°C
for 5 min prior to 5-fold dilution with RIPA buffer. Immu-
noprecipitated proteins were eluted by boiling in SDS-
loading buffer. Samples were analyzed by 15% SDS-PAGE,
and gels were fluorographed at -80°C (8).
Sequencing of viral proteins. Radiolabeled NS2B was
prepared from infected BHK cell lysates by preparative
immunoprecipitation. Cells (2 x 107) labeled with [35S]
methionine or cells (6 x 107) labeled with [3H]leucine were
lysed in 4 ml of denaturing lysis buffer and then diluted in
RIPA buffer for immunoprecipitation. Immunoprecipitates
were washed three times with RIPA and twice with 10 mM
ammonium bicarbonate buffer (pH 7.0) prior to being eluted
into 250 pAl of 0.1% trifluoroacetic acid and blotted onto glass
fiber discs (30). In vitro-processed NS2B was isolated by
preparative immunoprecipitation of denatured reticulocyte
lysates. Fifty microliters of a pTll-programmed [35S]methi-
onine- or 200 pul of a [3H]leucine-labeled translation mix was
denatured and diluted in RIPA buffer prior to immunopre-
cipitation. For sequencing of P2B3' precursors, 50 pI of a
pTll [35S]methionine-labeled translation mix was fraction-
ated by SDS-PAGE and then electroblotted onto Immobilon
PVDF (Millipore Corp., Bedford, Mass.) membranes by
using a carbonate-based buffer system (16, 36).
For sequencing of P3' produced in vitro, 200 jil of a pTll-
programmed [3H]leucine-labeled translation mix or 300 RI of
a [3H]valine-labeled translation mix was fractionated by
SDS-PAGE and then electroblotted onto Immobilon mem-
branes. Immobilon membranes were autoradiographed to
locate [35S]methionine-labeled P3' markers, and adjacent
lanes containing [3H]leucine- or [3H]valine-labeled P3' were
excised. Samples labeled in vivo or in vitro were sequenced
on a gas-phase sequenator (model 477A; Applied Biosys-
tems) without phenylthiohydantoin derivatization by using a
customized ATZ-1 program. Radioactivity in the eluate of
each cycle was determined in a liquid scintillation counter,
and 3H-counting efficiency was determined to be 40% by
using calibration standards.
RESULTS
Production of fusion proteins and specificity of antisera. We
have produced monospecific immune reagents reactive with
NS2B and NS3 by constructing plasmids (pTNS2 and
pTNS3) which express these moieties as fusion proteins with
trpE. The locations in the dengue virus genome of the inserts
used are shown in Fig. 1, which also illustrates schematically
the posttranslational processing of the dengue virus polypro-
tein to give the mature structural and nonstructural proteins.
When bacterial cultures harboring either pTNS3 or pTNS2
were induced and insoluble inclusion bodies were purified
and analyzed by SDS-PAGE, fusion proteins of 51 and 54
kilodaltons (kDa), respectively, were found (Fig. 2A), indi-
cating that the fusion proteins were stable when overex-
pressed. Fusion proteins were purified by preparative SDS-
PAGE and used to inject two rabbits each. High-titer
antiserum was usually obtained with three injections.
Denatured lysates of dengue virus-infected cells were
analyzed by using antisera directed against pTNS2 and
pTNS3 fusion proteins. Serum from a rabbit injected with
the pTNS2 fusion protein immunoprecipitated a protein of
approximately 14 kDa, identified as NS2B from its molecular
size, immunoreactivity, and N-terminal sequence (see be-
low), from infected but not from mock-infected cell lysates
(Fig. 2B), and the serum was therefore designated aNS2B
serum. NS2B was immunoprecipitated from denatured but
not from nondenatured lysates, implying that its immunore-
active epitopes are linear in nature or are masked in nonde-
natured lysates (data not shown). Since pTNS2 contains the
last 19 amino acids of NS2A as well as the first 111 amino
acids of NS2B (Table 1), antiserum raised against the en-
coded fusion protein could theoretically have reacted with
NS2A sequences. However, no NS2A protein (predicted
size, 24 kDa) was detected when either denatured (Fig. 2B)
or nondenatured (data not shown) lysates were immunopre-
cipitated with otNS2B.
Serum from a rabbit injected with the pTNS3 fusion
protein precipitated a polypeptide of 69 kDa, identified as
NS3, from infected cell lysates (Fig. 2B). In addition, three
larger proteins (85, 93, and 130 kDa) were present in signif-
icant amounts in the immunoprecipitates. All four species
were also immunoprecipitated by a polyvalent anti-dengue
virus mouse hyperimmune ascitic fluid (Fig. 2B, lane HIS).
The 93-kDa protein appears to be NS5, and the reason it
should precipitate with the atNS3 antiserum is obscure. The
size and reactivity of the 85-kDa protein are consistent with
it being polyprotein NS34A. The identity of the 130-kDa
species is unknown; it may be a polyprotein containing NS3.
Since pTNS3 encodes the last 8 amino acids of NS2B as
well as the first 141 amino acids of NS3 (Table 1), antiserum
raised against the encoded fusion protein could, in theory,
also precipitate proteins containing NS2B sequences. aNS3
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FIG. 1. Genome organization and expression of dengue virus type 2. A schematic diagram aligning the trpE cDNA fusions to their
corresponding regions of the dengue virus genome is shown. The upper third of the figure details the genome organization of the PR159 strain.
The middle third of the figure depicts the processing events generating the structural and nonstructural proteins. Virion structural proteins
are designated by shaded boxes, and nonstructural proteins are designated by open boxes. Cleavages after dibasic residues are designated by
arrows. Host cell signalase cleavages are designated by open ball-and-stick icons, and a potential viral-encoded signalase-like cleavage is
designated by a crosshatched ball-and-stick icon. A late, cell membrane-associated cleavage generating the membrane structural protein is
designated by a ball and arrow. The boundaries of the dengue virus inserts in the pTNS2 and pTNS3 cDNA fusions are mapped on the
expanded view of NS2A, NS2B, and NS3 shown in the lower third of the figure. Full details of constructs pTNS2 and pTNS3 are given in
Table 1. nt, Nucleotides.
serum immunoprecipitated small amounts of NS2B from
nondenatured lysates (data not shown) but not from dena-
tured lysates (Fig. 2B). Thus, with denatured lysates, the
aNS2B and oaNS3 sera described here are essentially mono-
specific, and denatured lysates were used for all immunopre-
cipitations shown in the figures.
In vitro translation and processing kinetics. Processing of
flavivirus nonstructural proteins occurs very rapidly in vivo,
and viral polyproteins can be detected only in pulse-chase
experiments under special labeling conditions (10). How-
ever, it seemed likely that these processing events could be
monitored upon translation in vitro. Our initial expression
experiments used RNA transcripts of dengue virus type 2
cDNA clones that were not engineered to have specific 5'
leader sequences or initiation codons in an appropriate
context. Only low levels of protein synthesis were obtained
in vitro, and variable amounts of specific (i.e., at the 5'
methionine in the RNA) versus nonspecific (internal) initia-
tion of translation were observed. Levels of expression were
increased approximately fivefold by inserting the dengue
virus 5' nontranslated region upstream of the region to be
translated. The efficiency of translation was increased an
additional two- to threefold when the reading frame of
interest was fused to that of the dengue virus capsid protein,
such that the mRNA translated had the authentic dengue
virus type 2 leader and the initiation codon in the normal
dengue virus context (data not shown). The yellow fever
virus 5' nontranslated region has also been shown to en-
hance expression of heterologous coding sequences by re-
ticulocyte lysates (43).
The first construct tested for protease activity was pT10.
RNA transcribed from this construct with T7 RNA polymer-
ase was translated into a polyprotein (P2A2B3) containing
the first 37 amino acids of the capsid protein, the C-terminal
118 amino acids of NS2A, all of NS2B, and most of NS3
(Fig. 3; Table 2). Protein patterns resulting from different
times of translation of this RNA in reticulocyte lysates are
shown in Fig. 4A. A protein with the molecular mass
predicted for the slightly truncated NS3 (P3) was produced
(Fig. 4A), showing that proteolytic processing had occurred
in this in vitro system. Proteins with molecular masses
predicted for the full-length (unprocessed) translated precur-
sor P2A2B3 and for the processing intermediate P2B3 were
also observed (Fig. 4A).
Since the pTlO construct contains two cleavage sites,
different processing intermediates would be predicted, de-
pending upon the temporal order in which the cleavages
occur. If the cleavage between P2A and NS2B preceded the
cleavage between NS2B and P3, intermediate P2B3 would
be generated. Conversely, if cleavage between NS2B and P3
TABLE 1. trpE/dengue virus cDNA fusions
Construct Vector" Gene Insertb Amino acidsb Proteinc
pTNS3 pATH3 (Eco(K)lSal) NS2B3 4497-4944 (Asp(K)/Sal) 122-129/1-144 NS3
pTNS2 pATH3 (Bam(K)/Cla) NS2A2B 4077-4463 (StulHpaII) 200-218/1-111 NS2B
a Vector and insert DNAs were prepared as described in Materials and Methods. (K), 5' overhangs that were blunted by Klenow treatment.
b Nucleotides are numbered relative to the dengue virus genomic sequence, and amino acid numbers of individual gene products are listed.
c Dengue virus-specific protein recognized by each antiserum under denaturing conditions.
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FIG. 2. trpE/dengue virus fusion proteins and characterization of
antisera. (A) Coomassie blue-stained SDS-PAGE gel with samples
of purified inclusion bodies from induced cultures of XL1 alone and
XL1 cultures containing plasmids pTNS3 and pTNS2. The positions
of protein standards (Bio-Rad Laboratories, Richmond, Calif.) are
shown to the left with the molecular masses (kilodaltons) indicated.
(B) Immunoprecipitates of [35S]methionine-labeled infected and
uninfected BHK cells analyzed by SDS-PAGE. A total of 105
infected (I and PI) or mock-infected cells (U) were labeled for 12 h,
beginning at 30 h postinfection. Lysates were immunoprecipitated
with a polyvalent mouse hyperimmune ascitic fluid (HIS) or mono-
specific aNS2B and aNS3 immune (I) and preimmune (PI) sera.
Locations of bands containing the viral proteins E, NS1, NS2B,
NS3, and NS5 and the putative precursor NS34A are indicated. The
molecular masses (kilodaltons) of 14C-labeled protein markers (Am-
ersham) are shown.
preceded cleavage between P2A and NS2B, P2A2B rather
than P2B3 would be produced. The potential precursor
P2A2B was not observed by SDS-PAGE (Fig. 4A) or by
immunoprecipitation with xNS2B serum (see below), but
P2B3 was readily detected as described above, suggesting
that cleavage at the 2A/2B junction occurred first. The
amounts and processing kinetics of P2B3 were also consis-
tent with the view that it is the major intermediate in the
processing pathway (see below).
Bands containing P2A2B3, P2B3, and P3 (Fig. 4A) were
excised from the dried gel, solubilized, and assayed for
radioactivity (Fig. 4B). The translations were conducted by
TABLE 2. Deletion constructs
Construct Gene" Amino acid deletionb
pTlO NS3 611-618
pTll NS3 303-618
pT12 NS3 184-618
pT13 NS3 141-618
pT14 NS2B/NS3 122-129/1-618
pT15 NS2B/NS3 43-121/303-618
pT16 NS2A/NS2B/NS3 146-218/1-42/184-618
a Genes affected by deletion.
b The amino acids deleted in individual gene products are listed. When
more than one gene product contains a deletion, amino acid numbers are
separated by a shill.
using an RNA concentration of 10 ,ug/ml, conditions under
which initiation of translation occurs nearly synchronously
and the reticulocytes lose their ability to initiate new poly-
peptide chains after approximately 30 min of translation (14).
Thus, the kinetics of accumulation and processing exhibited
two phases. All three species accumulated with similar half
times during the first 30 min (synthesis phase). After 30 min
of translation (postsynthesis phase), there was no further
incorporation of label into newly synthesized protein. The
label in the full-length P2A2B3 band remained constant
between 30 and 90 min, indicating that these molecules were
stable and were not processed, whereas P2B3 decayed with
a half-life of 42 min and P3 accumulated at the same rate,
suggesting a precursor-product relationship between these
two species. The fact that P2A2B3 appeared to be processed
rapidly in the first 30 min but appeared to be stable thereafter
suggests that folding of this protein does not occur optimally
during translation in reticulocyte lysates and that those
molecules that fold correctly during the initial synthesis
phase are processed rapidly, while misfolded molecules are
processed slowly or not at all. The fraction of P2A2B3 that
was processed varied from experiment to experiment, being
sensitive to the lot of reticulocyte lysate used and to other
unknown variables.
Cleavage of the dengue virus polyprotein in cis. Intermo-
lecular (trans) cleavages exhibit second-order kinetics and
are concentration dependent, whereas intramolecular (cis)
cleavages are first order and concentration independent. To
determine whether the cleavages at the dengue virus 2A/2B
and 2B/3 sites were concentration dependent, we examined
the protein products obtained upon translation of different
amounts of input RNA, which effectively changes the con-
centration of the proteinase (Fig. 4C). At the highest con-
centrations of RNA tested, the components of the transla-
tion system were limiting (29) and processing appeared to
proceed more rapidly. At lower concentrations of RNA,
pTlO
(1-37) (101-218) (1-129)
T7
1 P2A NS2BSSSS
1 1-213+ <
(1-610) amino acids.. _/
- nucleotides
FIG. 3. Schematic diagram of dengue virus type 2 protein and nucleic acid sequences expressed in the translation vector pT10. T7 RNA
polymerase transcribes a chimeric RNA which contains nucleotides 1 to 213 fused to nucleotides 3778 to 6351 of the dengue virus genome.
An initiator methionine codon at position 96 is designated by a closed diamond. Upon translation, the encoded polyprotein contains amino
acids 1 to 37 of the dengue virus capsid protein, amino acids 101 to 218 of NS2A, all of NS2B, and the first 610 amino acids of NS3 ( ).
The predicted protease domain of NS3 is indicated (M).
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FIG. 4. Processing of proteins during in vitro translation of construct pT10. (A) Samples of a pTlO-programmed translation were removed
at the designated times (min) after initiation of translation and analyzed by SDS-PAGE. Precursors P2A2B3 and P2B3 as well as mature P3
are indicated. (B) Bands containing P2A2B3, P2B3, and P3 were excised from gels like that shown in panel A and quantitated as described
in the text. (C) Samples ofRNA transcribed from pTlO were serially diluted and translated in vitro. Samples of the translation mixtures were
analyzed by SDS-PAGE. In order to equalize for [35S]methionine incorporation, various amounts of lysate were loaded in each lane. Lanes
1 to 4 contained 1 p.l of lysate; lanes 5, 6, 8, and 10 contained 2 p.l of lysate; and lanes 7, 9, and 11 contained 4 pul of lysate. Mass of RNA
per milliliter and the length of the translation incubation (min) are indicated. Locations of bands containing nonstructural protein precursors
P2A2B3 and P2B3 as well as mature P3 are indicated.
total incorporation appeared to increase between 25 and 90
min of translation and proportionately more label was
present in a 46-kDa reticulocyte-specific band. However, the
ratio of P2A2B3 to P3 after 90 min of translation at 30°C
appeared to be independent of the concentration of input
RNA (Fig. 4C), suggesting that cleavage occurs in cis,
although extremely efficient trans cleavage by the dengue
virus proteinase cannot be ruled out.
We have used a second approach to examine whether the
dengue virus polyprotein can be cleaved in trans. Polypro-
teins produced by pT13- and pT14-programmed translations
contain an inactive protease, but the potential cleavage sites
are intact (see below). These polyproteins were used as
substrates for the active proteinase produced by a pT10-
programmed translation, and no detectable cleavage of these
polyproteins occurred (data not shown). The lack of detect-
able trans cleavage in these experiments is consistent with
the results of the kinetic and dilution sensitivity experiments
which suggested that cleavage occurred at the 2A/2B and
2B/3 junctions only in cis.
Deletion mapping of the dengue virus protease. On the basis
of molecular modeling studies, both Bazan and Fletterick (3)
and Gorbalenya et al. (21) have predicted the precise bound-
aries of the flavivirus protease domain. This predicted do-
main is illustrated schematically in Fig. 5 in relation to the
dengue virus polyprotein. The entire domain is hypothesized
to span the first 180 amino acids of NS3 (solid boxes) and to
contain four subregions or boxes of homology with serine
proteases, the first three of which contain the three elements
of the catalytic triad and the fourth of which is involved in
substrate binding. To test these predictions, we constructed
a series of deletion constructs that together span the entire
length of NS3 and that delete large regions of P2A and NS2B
(Fig. 5; Table 2); translation mixes were programmed with
RNA transcribed from these constructs, and the resulting
protein products were immunoprecipitated with aNS2B and
cxNS3 sera and analyzed by SDS-PAGE (Fig. 6).
Constructs pT10, pTll, and pT12 contain the entire pro-
posed protease domain (Fig. 5), and from these constructs
polypeptides with the molecular masses and immunoreactiv-
ities of mature NS2B and of the truncated forms of NS3 (P3,
P3', and P3") were detected (Fig. 6A). In contrast, pT13-
programmed translations did not produce any (truncated)
NS3 or NS2B (Fig. 6B), indicating that this deletion abol-
ished activity, presumably by invading the protease domain
(Fig. 5). Thus, the protease domain encompasses a maxi-
mum of 184 amino acids at the N terminus of NS3. Polypep-
tides consistent in molecular mass and immune reactivity
with a P2B3 processing intermediate could also be detected
in pTlO-, pTll-, and pT12-programmed translations but not
in pT13-programmed translations (Fig. 4 and 6).
Translation of RNA transcribed from pT14 yielded a
polypeptide which was consistent in molecular mass and
immunoreactivity with that predicted for P2A2B'. Process-
ing did not occur at the 2A/2B site. The location of the band
and the amount expressed from pT14 were such that if this
precursor had been present upon translation of RNA from
constructs such as pT10, it would have been readily de-
tected. This supports the earlier conclusions that P2A2B was
never generated during processing in vitro.
To examine the N-terminal boundary of the protease
domain, that is, whether sequences in P2A or NS2B are
C.
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FIG. 5. Schematic map of deletion constructs used to map pro-
tease activity. The relative positions of the four homology boxes
proposed by Bazan and Fletterick (3) and Gorbalenya et al. (21) are
shown. The proposed catalytic histidine, aspartate, and serine
residues are listed within boxes 1, 2, and 3 and indicated by vertical
lines on the schematic map. SBP refers to the proposed substrate-
binding pocket. Gene products P2A and NS2B are designated by
open and stippled boxes, respectively. Capsid protein is indicated
by hatched lines. The putative protease and helicase domains of
NS3 are designated by solid and crosshatched boxes, respectively.
The structures of deletion clones are mapped below. The abbrevia-
tions for restriction sites used to generate deletion constructs are
indicated as follows: A, Asel; P, PvuII; Sn, SnaBI; K, KpnI
(Asp718); D, DraIll; S, Sall; As, AsulI; X, XhoI; and E, EcoRI.
Cleavages at the 2A/2B or 2B/3 junctions are indicated by arrows. A
detailed description of each construct is given in Table 2.
required for proteolytic activity, we analyzed the in vitro
translation patterns produced from two deletion constructs,
pT15 and pT16, which together delete almost all the P2A and
NS2B sequences. When pT15-programmed translations
were fractionated by using aoNS2B, only low levels of
immunoreactive species were observed upon overexposure
of autoradiographs (Fig. 6B). The molecular masses of these
species were not consistent with correct processing at the
2A/2B or 2B/3 cleavage site. The low level of immunoreac-
tivity suggests that the major antigenic epitopes recognized
by aNS2B have been deleted in this construct. Upon pre-
cipitation with aNS3, a small amount of aberrantly proc-
essed P3' was detected. When pT16-programmed transla-
tions were immunoprecipitated and analyzed by SDS-
PAGE, both oaNS2B- and aNS3-immunoreactive species of
aberrant molecular mass could be detected. Since the 2A/2B
cleavage site had been removed by this deletion, only
cleavage at the 2B/3 boundary could be examined. Thus, it is
unclear whether sequences in P2A or NS2B are required for
proteolytic activity or whether the deletions induce misfold-
ing of the molecule such that the correct cleavage sites are
not recognized.
Sequencing of viral proteins. In order to confirm that the
cleavage events observed in vitro occur at the same sites as
those utilized in vivo and to confirm the identities of the
proteins produced in vitro, we compared the amino-terminal
amino acid sequences of NS2B and NS3 produced in vitro
with those of proteins isolated from infected cell lysates and
obtained the N-terminal sequence of P2B3'. NS2B from
IH- _ A -14_NS2B
FIG. 6. Immunoprecipitations of in vitro translations pro-
grammed with RNA transcribed from NS3 deletion constructs. (A)
Samples of reticulocyte lysates were denatured and immunoprecip-
itated with aNS2B (marked by 2) or aNS3 (marked by 3) immune
sera, and immune complexes were dissolved in SDS-containing
loading buffer and analyzed by SDS-PAGE. The construct from
which RNA was transcribed is indicated above each lane. Protein
species which were identified as P2A2B3", P2B3", P3, P3', P3",
and NS2B by immunoreactivity and molecular mass are indicated.
The molecular masses (kilodaltons) of "'C-labeled protein standards
(Amersham) are indicated. (B) Immunoprecipitations of in vitro
translations from proteolytically inactive templates. Unprocessed
precursors P2A2B3" and P2A2B' are designated as are the positions
of molecular mass markers.
dengue virus type 2-infected cells labeled with [35S]methio-
nine or [3H]leucine was isolated by preparative immunoaf-
finity chromatography. Approximately 85% of the label in
the purified NS2B used for sequencing consisted of mature
NS2B, as determined by electrophoresis. The results clearly
showed that serine 1345 of the dengue virus polyprotein is
the amino-terminal residue of NS2B produced in vivo (Fig.
7A). This assignment is in agreement with data for other
sequenced NS2B species (9, 48, 54), on the basis of sequence
homology.
In order to sequence NS2B produced in vitro, pTll-
programmed translations were immunoprecipitated with
aNS2B. Approximately 85% of the NS2B immunoprecipi-
tated was fully cleaved, and approximately 10% of the label
was in P2B3', which is coterminal with mature NS2B and
contributes to the observed NS2B signal (see below). The
amino terminus of in vitro-produced NS2B was indistin-
guishable from that found in vivo (Fig. 7B).
Sequencing of P3' labeled in vitro in pTll-programmed
translations identified the amino-terminal residue of P3' as
Ala-1476 of the dengue virus type 2 polyprotein (Fig. 7C).
Peaks of [3H]leucine at cycles 4 and 18 and of [3H]valine at
cycles 3, 7, and 13 make this assignment unambiguous. This
result agrees perfectly with the sequence of NS3 isolated
from dengue virus type 2-infected cells (4). The P3' results
are also of interest because the cleavage which produces the
amino terminus of dengue virus type 2 NS3 is unique in that
it appears to occur after a single basic amino acid; the
cleavages to produce NS3 in all other sequenced flaviviruses
occur after dibasic residues. The fact that the amino termi-
nus of P3' produced in vitro is the same as that of NS3
isolated from infected cells suggests that the dengue virus
2B/3 cleavage site is in fact different and that the observed
terminus of NS3 does not arise from cleavage at an upstream
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-69
J. VIROL.
40
FLAVIVIRUS NONSTRUCTURAL PROTEIN PROCESSING 4371
CYCLE
[35S] Met
[3H1 Leu
[35S] Met
---
131H Leu
[3H] Leu
[3H] Val
[35S] Met
ED
CYCLE
FIG. 7. Amino-terminal sequencing of viral proteins. Data in each panel are plotted as radioactivity per Edman degradation cycle versus
cycle number. (A) In vivo-labeled NS2B. (B) In vitro-labeled NS2B. (C) In vitro-labeled P3'. (D) Precursor P2B3'. The amino-terminal
sequences of NS2B, NS3, and NS2B3 deduced from the nucleotide sequence of the RNA genome are indicated below each sequence panel,
with the leucine, valine, and methionine residues identified by Edman degradation highlighted in boldface capital letters. The burst of 35S
disintegrations per minute observed in the first sequencing cycle of immunoaffinity-purified NS2B (both in vivo and in vitro) is not consistent
with the deduced sequence of NS2B and is presumably contributed by contaminants which coprecipitate with NS2B. The single-letter amino
acid code used is as follows: A, alanine; C, cysteine; D, aspartate; E, glutamate; F, phenylalanine; G, glycine; H, histidine; I, isoleucine; K,
lysine; L, leucine; M, methionine; N, asparagine; P, proline; Q, glutamine; R, arginine; S, serine; T, threonine; V, valine; W, tryptophan; and
Y, tyrosine.
site characterized by dibasic residues followed by amino-
terminal nibbling (4).
In order to define further the specificity of cleavage events
and definitively identify processing intermediates, the puta-
tive P2B3' was isolated from pTll-programmed translations
by preparative SDS-PAGE and sequenced. Peaks of 35S
were observed at positions 9 and 13, aligning this species
perfectly with the amino terminus of NS2B and confirming
the previous identification based on gel mobility and immuno-
reactivity (Fig. 7D).
DISCUSSION
Cleavage of the dengue virus polyprotein in vitro. The
kinetic experiments indicated that in vitro cleavage at the
2A/2B junction precedes that at the 2B/3 junction. These
junctions were inactive as substrates in a trans cleavage
assay and cleavage was insensitive to dilution, implying that
cleavage at these two junctions occurs by an intramolecular
mechanism. It is formally possible that NS3 is extremely
active in trans such that sensitivity to dilution could not be
demonstrated and that the negative results of the trans-
processing experiments resulted from the perturbed tertiary
structure of substrates, although we have used similar meth-
ods to demonstrate trans cleavage of the Sindbis virus
nonstructural polyprotein (29). Differences in the rate of
translation and in the association of membranes with proc-
essing intermediates could also influence the observed rate
of cleavage in vivo.
Cleavage at the 2A/2B and 2B/3 junctions in vitro proceeds
with the same specificity as that found in vivo. Translation
products are cleaved at the correct sites of cleavage, and
nonspecific cleavage is rarely observed. While the kinetics of
cleavage in vitro are much slower than those observed in
vivo, it is highly probable that the fidelity and order of in
vitro cleavage are a true reflection of in vivo processing. The
use of improved expression systems and in vitro mutagene-
sis of cleavage sites will be useful in establishing whether the
order of cleavage observed is obligatory or whether it simply
represents the kinetically favored order.
Testing the flavivirus protease model. Positive identifica-
tion of NS3 as a flavivirus proteinase will stimulate research
on the nature of the catalytic and substrate recognition
residues involved in proteolysis. The specific predictions as
to which histidine, aspartate, and serine residues form the
catalytic triad are testable through site-specific mutagenesis,
and mutants which are catalytically active in vitro can be
tested for biological activity in vivo through the use of
infectious cDNA clones (40). NS3 shares the greatest
amount of sequence similarity with the Sindbis virus capsid
protein protease domain, and site-directed mutagenesis of
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the NS3 protease domain will be greatly assisted by molec-
ular modeling studies once the coordinates of the Sindbis
capsid protein become available (5).
Four specific predictions of the protease model were
addressed by experiments presented here (3, 21). Our exper-
imental results are consistent with the predictions that the
protease domain consists of approximately 180 amino acids
at the N terminus of NS3 and could retain function when
severed from the remainder of NS3, which forms a putative
helicase domain. However, our results are not consistent
with the prediction that an internal conserved cleavage site
in NS3 is utilized to separate the helicase and protease
domains or the prediction that cleavage of the flavivirus
polyprotein by NS3 is an ATP-dependent process. The
antiserum used in our experiments was directed specifically
against the protease domain, and therefore any internal
cleavage of NS3 in vitro or in vivo should have been
detected. Proteolysis occurred even in those cases in which
the helicase domain had been deleted, making it unlikely that
hydrolysis of ATP is absolutely required for proteolysis,
although the possibility that it has an effect in vivo has not
been eliminated.
The presence of protease and helicase domains within a
single viral protein is a common structural motif found in
alphavirus, pestivirus, potyvirus, and coronavirus proteins
as well as flaviviruses (22). The primary function of a viral
proteinase is to posttranslationally regulate the production of
individual gene products from a polyprotein precursor. The
viral proteinase can also produce processing intermediates
which may themselves be functional components of the viral
life cycle. The choice between emphasizing proteinase func-
tion and emphasizing helicase function would depend on the
specific needs of the virus at that point in the life cycle. It
appears likely that the main function of mature NS3 is as a
helicase, since the initial cleavages releasing NS2B and NS3
most likely occur in cis and mature NS3 does not appear to
work efficiently in trans.
Implications for dengue virus polyprotein processing. A
number of viral proteinases function both in cis and in trans
to cleave polyproteins in vivo (32). Like other proteinases of
positive-stranded RNA viruses, NS3 may also function both
in cis and in trans. The amino terminus of NS4B is believed
to be generated by a signalase cleavage event which presum-
ably occurs cotranslationally upon insertion of the hydro-
phobic tail of NS4A into the lumen of the endoplasmic
reticulum (9, 48). Once this event occurs, the dengue virus
polyprotein backbone is severed, and by definition, any
processing events that occur downstream of this scission
must occur in trans, and if NS3 is the proteinase responsible
for cleavage at the 4B/5 boundary then it must cleave in
trans.
Processing events consistent with scission at the 3/4A
junction are observable in vitro (F. Preugschat, unpublished
data), and putative NS34A intermediates can be detected in
vivo (Fig. 2B). This implies that the kinetics of 3/4A cleavage
are slower than the kinetics of 2A/2B and 2B/3 cleavage. It is
possible that NS34A is a precursor that is restricted to the
plane of the endoplasmic reticulum by a carboxy-terminal
membrane-spanning segment and that this is the form of
proteinase that is responsible for trans cleavage at the 4B/5
junction. By restricting the proteinase to the plane of the
endoplasmic reticulum, the concentration dependence of the
trans cleavage step would be reduced and result in rapid
kinetics of cleavage in infected cells.
The flavivirus capsid protein undergoes a complex two-
step maturation process in infected cells. As the carboxy
terminus of the capsid protein is translated, it acts as a
membrane insertion sequence for a cotranslational signalase-
mediated cleavage that generates the amino terminus of the
prM protein. Nascent intracellular capsid protein possesses
a C-terminal membrane-spanning segment that is cleaved
prior to assembly of the virion (37). This cleavage event
occurs on the carboxy-terminal side of several basic residues
and could be potentially mediated in trans by NS3. The
initial signalase-mediated cleavage can be observed by using
an in vitro translation system, but the secondary maturation
cleavage that removes the membrane insertion sequence has
not been observed in vitro (37, 44). By using an in vitro
expression system designed to analyze cleavages at the
3/4A, 4B/5, and C/prM junctions, it should be possible to
reconstruct the flaviviral protein-processing pathway by
using the experimental approaches described in this paper.
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